Examining the utility of using genotype and functional biology in a clinical pharmacology trial: pilot testing dopamine β-hydroxylase, norepinephrine, and post-traumatic stress disorder

Psychiatr Genet. 2014 Aug;24(4):181-2. doi: 10.1097/YPG.0000000000000039.
No abstract available

Publication types

  • Letter
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Clinical Trials as Topic
  • Dopamine beta-Hydroxylase / genetics*
  • Genotype
  • Humans
  • Imidazoles / therapeutic use*
  • Norepinephrine / metabolism*
  • Pilot Projects
  • Stress Disorders, Post-Traumatic / drug therapy*
  • Stress Disorders, Post-Traumatic / enzymology
  • Stress Disorders, Post-Traumatic / genetics*
  • Thiones / therapeutic use*

Substances

  • Imidazoles
  • Thiones
  • Dopamine beta-Hydroxylase
  • nepicastat
  • Norepinephrine